×
DECIDE Study – Investigating the effectiveness of dapagliflozin
6th February 2019
DECIDE is a pioneering real-world pragmatic trial investigating the effectiveness of dapagliflozin compared to standard of care for second line treatment.
An opportunity has arisen for practices to take part in a research study in collaboration with the Greater Manchester Clinical Research Network.
You may have worked with us before but should this be new to you, we are happy to offer support and guidance.
Please find the research information sheet here for your consideration.